Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors

Even patients with SEVERE kidney disease seem to benefit from ACE inhibitors.

We know that ACE inhibitors slow the progression of kidney disease in patients with mild to moderate kidney disease...but many prescribers are wary about using them for severe disease.

Researchers are now showing that low-dose benazepril reduces proteinuria AND postpones dialysis or transplant in patients with stage 4 kidney disease. These are patients who have glomerular filtration rates of 15-29 mL/min/1.73 m2.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote